Raltegravir And Darunavir Antiretroviral in Antiretroviral Naive Patients (RADAR)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2012 by Dallas VA Medical Center.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
Merck Sharp & Dohme Corp.
Tibotec Pharmaceutical Limited
Information provided by (Responsible Party):
Roger Bedimo, M.D., Dallas VA Medical Center
ClinicalTrials.gov Identifier:
NCT00677300
First received: May 8, 2008
Last updated: August 31, 2012
Last verified: August 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2012
  Estimated Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)